The CBD Jaw-Pain Regimen Included Holding Oil Under the Tongue and Swallowing
Participants in the CBD jaw-pain trial held the oil under the tongue for sixty seconds and then swallowed it. That procedure defines the tested regimen more precisely than calling it simply oral or sublingual CBD.
Administration involved two stages
The active regimen supplied 20 mg CBD daily in 1 mL of oil over three months. The comparator was 1 mL hemp seed oil without detectable CBD. The study concerned myofascial pain in the muscles used for chewing.
Holding oil in the mouth followed by swallowing does not reveal what proportion of the administered CBD entered through the oral mucosa and what proportion was absorbed after swallowing. The trial did not measure plasma CBD to resolve that question.
A route label cannot supply a measured exposure
The clinical outcomes were patient-reported pain and jaw-function scores. No statistically significant between-group pain advantage was demonstrated at the reported follow-ups, and jaw-function improvement in both groups did not establish CBD superiority.
It would be unsupported to turn this clinical result into a specific blood concentration, absorption percentage or finding of inadequate exposure. It would also be unsupported to assume that another oil, holding time or swallowed formulation would necessarily produce an identical result.
Describe the regimen before generalizing
A useful treatment claim states the dose, oil formulation, holding-and-swallowing procedure, diagnosis and comparator. These details preserve the trial’s scope without changing its null between-group result. The small single-center study, adherence limitations and commercial support also belong in an appraisal. This was human clinical research, not an animal experiment or an impairment test.
Related analysis: the CBD jaw-pain trial’s pain and function results.
Research cited
Reeve and colleagues (2026), Oral Cannabidiol in the Treatment of Myofascial Pain Disorder of the Temporomandibular Region: A Placebo-Controlled Randomized Clinical Trial. DOI: 10.1159/000551040.
